Registration Coming Soon
NewBridge Pharmaceuticals, headquartered in Dubai, UAE, is a regional specialty company with a comprehensive pharmaceutical platform of services and expertise, established to bridge the access gap and partner with global pharma and biotech companies to in-license and commercialize U.S. FDA or EMA approved innovative therapeutics that address unmet medical needs into the Middle East and North Africa (MENA) regions.
Novartis is reimagining medicine to improve and extend people’s lives. As a leading global medicines company, we use innovative science and digital technologies to create transformative treatments in areas of great medical need. In our quest to find new medicines, we consistently rank among the world’s top companies investing in research and development. Novartis products reach nearly 1 billion people globally and we are finding innovative ways to expand access to our latest treatments. About 125 000 people of more than 140 nationalities work at Novartis around the world.
We are an innovative global healthcare company, driven by one purpose: we chase the miracles of science to improve people’s lives. Our team, across some 100 countries, is dedicated to transforming the practice of medicine by working to turn the impossible into the possible. We provide potentially life-changing treatment options and life-saving vaccine protection to millions of people globally, while putting sustainability and social responsibility at the center of our ambitions
Merck Group is a leading global science and technology company headquartered in Darmstadt, Germany. The company operates across three main sectors: Healthcare, Life Science, and Electronics. With around 60,000 employees in more than 60 countries, Merck focuses on developing innovative solutions to improve health and quality of life. Its Healthcare business delivers treatments for serious diseases, while Life Science supports research and biotechnology, and Electronics drives advancements in digital technologies. Guided by a strong commitment to science and sustainability, Merck aims to address global challenges and create long-term value for society through innovation and responsible operations
merck.com
Mundipharma is a global healthcare company committed to advancing therapies that address areas of significant clinical need.
Through rigorous research, strategic collaborations, and a sustained focus on patient outcomes, we deliver solutions that support healthcare professionals and strengthen standards of care.
Our antifungal portfolio includes REZZAYO® (rezafungin), a next-generation echinocandin developed to provide once-weekly dosing for adults with invasive candidiasis.
This innovation reflects our broader mission: to bring clinically meaningful advancements to complex therapeutic areas while fostering reliability, quality, and scientific excellence across the healthcare ecosystem.
AMGEN: TURNING INNOVATION INTO REAL-WORLD VALUE
Amgen is a global biotechnology company focused on discovering, developing, and delivering innovative medicines for serious diseases, with a clear mission to improve patient outcomes while supporting sustainable healthcare systems.
Amgen continues to advance a strong portfolio of therapies across high-burden diseases, including cardiovascular conditions, obesity and related diseases, rare diseases, inflammation, and cancer—driven by science and a commitment to meaningful clinical impact.
Amgen partners with healthcare stakeholders to generate and apply real-world evidence, supporting value-based healthcare decisions and improving patient access to innovative therapies
Novo Nordisk is a global healthcare company headquartered in Denmark, with a strong focus on chronic diseases that affect millions of people worldwide. We have been advancing treatment for diabetes, obesity and related conditions, as well as rare blood and endocrine disorders. Our pur-pose is to drive change to defeat disease and help patients live with greater confidence. Guided by innovation and evidence-based science, we develop therapies and devices that improve clinical outcomes and support long-term health. We collaborate with health authorities, payers, clinicians and policymakers to strengthen access, sustainability and value in healthcare systems. In the Middle East, we invest in local capabilities, patient support initiatives and workforce development, working alongside communities to ensure responsible, reliable supply. Sustainability is central to how we operate, from responsible sourcing to reduced environmental impact. We look forward to contributing expertise to the 6th Middle East Pharmacoeconomics & Drug Policy Summit this year.
About Roche
Founded in 1896, Roche is the world’s largest biotech company and a global leader in in-vitro diagnostics. The company combines strengths in Pharma and Diagnostics with clinical data to drive personalised healthcare. In the Middle East, Roche has provided pharmaceutical and diagnostic expertise for over 85 years across 15 countries. Learn more at www.roche-middleeast.com.
Since 1947, Roche has served as a strategic partner to the healthcare sector in the Kingdom of Saudi Arabia.
By establishing a fully-fledged legal entity and its office in Riyadh, Roche is committed to fostering long-term national partnerships that prioritize innovation and local capacity building.
Roche’s initiatives focus on enhancing the efficiency of the healthcare ecosystem in direct alignment with the objectives of Saudi Vision 2030 and the National Health Transformation Program, ensuring sustainable access to world-class diagnostic and therapeutic solutions for all patients in the Kingdom.
Mundipharma is a global healthcare company committed to advancing therapies that address areas of significant clinical need.
Through rigorous research, strategic collaborations, and a sustained focus on patient outcomes, we deliver solutions that support healthcare professionals and strengthen standards of care.
Our antifungal portfolio includes REZZAYO® (rezafungin), a next-generation echinocandin developed to provide once-weekly dosing for adults with invasive candidiasis.
This innovation reflects our broader mission: to bring clinically meaningful advancements to complex therapeutic areas while fostering reliability, quality, and scientific excellence across the healthcare ecosystem.
At Johnson & Johnson, we believe health is everything. Every day, our more than 130,000 employees globally are building a world where complex diseases are prevented and cured, treatments are smarter and less invasive—and solutions are personal. For 140 years, we have aimed to keep people well at every age and every stage of life.
We innovate across the full spectrum of healthcare solutions today to uniquely position us for the breakthroughs of tomorrow. As a focused healthcare company, with expertise in Innovative Medicine and MedTech, there are specific areas where we uniquely impact health in a way that only we can.
Patients inform and inspire our science-based innovations, which continue to change and save lives. With rigorous science and compassion, we confidently address the most complex diseases of our time and unlock the medicines of tomorrow.
Our diverse product portfolio spans multiple areas, where patient need is high and our expertise is deep:
• Oncology
• Immunology
• Neuroscience
• Cardiopulmonary
Learn more at JNJ.com
Bayer is a Life Science company with a more than 160-year history and core competencies in the areas of health care and agriculture. With our innovative products, we are contributing to finding solutions to some of the major challenges of our time.
Lilly unites caring with discovery to create medicines that make life better for people around the world. We’ve been pioneering life-changing discoveries for nearly 150 years, and today our medicines help more than 47million people across the globe. Harnessing the power of biotechnology, chemistry and genetic medicine, our scientists are urgently advancing new discoveries to solve some of the world’s most significant health challenges, redefining diabetes care, treating obesity and curtailing its most devastating long-term effects, advancing the fight against Alzheimer’s disease, providing solutions to some of the most debilitating immune system disorders, and transforming the most difficult-to-treat cancers into manageable diseases. With each step toward a healthier world, we’re motivated by one thing: making life better for millions more people. That includes delivering innovative clinical trials that reflect the diversity of our world and working to ensure our medicines are accessible and affordable.
Bold and nimble, Boston Oncology is an innovative biogenerics company redefining excellence in the licensing and local development, manufacturing and distribution of US- quality medicines – across therapeutic areas.
From our nerve center in Riyadh, we leverage the expertise, daring creativity, and unwavering determination of our international leadership team to provide customers with end-to-end, efficient, single-point-of-contact access to our diverse portfolio of world-class biogenerics.
AstraZeneca (LSE/STO/Nasdaq: AZN) is a global, science-led biopharmaceutical company that focuses on the discovery, development, and commercialisation of prescription medicines in Oncology, Rare Diseases, and Biopharmaceuticals, including Cardiovascular, Renal & Metabolism, and Respiratory & Immunology. Based in Cambridge, UK, AstraZeneca operates in over 100 countries and its innovative medicines are used by millions of patients worldwide.
Sobi is an international biopharmaceutical company focused on rare diseases. We are dedicated to providing access to innovative treatments that transform life for people with rare diseases. We focus on two therapeutic areas – Hematology and Immunology – and also have a portfolio of Specialty Care products. With our head office in Stockholm, Sweden, the Sobi organization spans more than 30 countries, delivering treatments to patients in over 70 countries across the globe. We see geographic expansion as an important aspect of our strategy, and are pursuing it through acquisitions, greater market penetration and by establishing operations in new markets.
Medical Tourism, is a quarterly, bilingual magazine published in English and Arabic started in 2016, on medical tourism in Asia. It has been shaped up as a great source of information about authentic medical facilities available in Asia for the benefit of those who seek cost-efficient and quality medical treatment abroad, especially in the Asian countries. We have focused on Asia as it is the most sought- afterdestination today among Arabs and westerners for medical treatment as advanced treatment facilities are available here at an affordable cost.
Medgate Today is one of the leading International Magazine of Healthcare, which is having a very strong presence in Asia . Headquartered in India and having a pan India presence on a larger scale, Medgate Today caters the Doctors and Hospitals in Asia. It is a unique platform catering to diverse health & lifestyle sectors It is a subsidiary of Advance Media Group having various publications across many domains.
Medgate Today has been catering to quality and authentic information needs of Indian medical fraternity & Industry as well as global medical industry.
Medgate Today a health centric magazine , has recognized the need for creating health awareness in India amongst the least informed sections of society where health education has been ignored due to lack of resources. Medgate Today Magazine aims to reach those outlets which can provide patients effective information & guidance and help them in their treatment decisions .
CoatConnect is the first Online Hub for Healthcare Professional & Educational Opportunities either online or offline i.e. Specialized Courses, Conferences, Exams, Jobs & much more!
A multi-sided marketplace that gives all Healthcare Professionals the chance to either showcase their educational opportunities, from courses, to conferences, jobs and hands-on training, or easily find & apply to relevant educational or professional opportunities.
Medical Buyer provides a direct interface between buyers and brands of medical equipment and devices. It is India’s premier magazine on MedTech, IVD, blood banking and life sciences equipment. Drawing on its strength of aggressive and comprehensive reporting, backed by market research, with editorial contribution from business thinkers and industry leaders, the magazine is a referral for the Indian buyer community including hospitals & nursing homes, diagnostic centers & path labs, blood banks, research labs & educational institutions and importers, distributors & dealers.
The web portal, www.medicalbuyer.co.in, is positioned as a preferred source for equipment buyers searching for vendors and product information. The portal provides an opportunity for vendors to build brand image, provide live business information, and generate customer leads. Other online promotions include weekly newsletters, EDM blasts, and e-zine version of the magazine.
The medical industry is advancing to a new era of incorporating the best of science into health care. Every day there are new technological innovations that make it easier for the doctors to help save thousands of lives.
Mediworld consists of all the latest technological innovations and improvements used in the medical industry that helps to solve the issues faced in health & medicine and depict the new generation of science employed in these fields.
Mediworld, the region’s trusted source of information for general health, is your gateway to keep up to date with the latest research and innovations in preventive health, aesthetics, health & Wellness, fitness, medicine and science.
About Gilead Sciences
Gilead Sciences, Inc. is a biopharmaceutical company that has pursued and achieved breakthroughs in medicine for more than three decades, with the goal of creating a healthier world for all people. The company is committed to advancing innovative medicines to prevent and treat life-threatening diseases, including HIV, viral hepatitis and cancer.
Pharma Focus Asia is a quarterly magazine from Ochre Media Pvt. Ltd. Pharma Focus Asia covers important issues and trends shaping the future of the Pharma industry across Asia and rest of the world. It is the leading Pharma title in print as well as digital versions serving the information needs of key executives from the world’s leading pharmaceutical companies. www.pharmafocusasia.com
Medarabia is the largest healthcare and medical network in the Middle East. It has been founded to empower the healthcare industry by enabling users to share their experiences and post reviews.